Amended Statement of Beneficial Ownership (sc 13d/a)
17 Abril 2017 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)
Provectus
Biopharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
74373F100
(CUSIP Number)
Courtlandt G. Miller
251 Royal Palm Way, Suite 205
Palm Beach, FL 33480
(561) 543-6802
with
copies to:
David W. Bernstein, Esq.
Goodwin Procter LLP
620
Eighth Avenue
New York, NY 10018
(212) 813-8808
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications)
April 14, 2017
(Date of Event Which Requires Filing of this Statement)
If the filing person has
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ☐.
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for
other parties to whom copies are to be sent.
(Continued on
following pages)
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Charles Littlejohn
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
1,936,550
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
1,936,550
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,936,550
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.53%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Jeffrey A. Morris
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
17,000,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
17,000,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
17,000,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
4.66%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
James F Boyle Jr Credit Shelter Trust
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
15,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
15,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
15,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.004%
|
|
14
|
|
Type of Reporting Person*
OO
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
John G. Gazonas
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
2,350,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
2,350,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,350,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.64%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
James D. Watson
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
500,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
1,000,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,000,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.27%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Times 11, LLC
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
OO
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
Delaware, United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
532,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
1,330,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,330,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.36%
|
|
14
|
|
Type of Reporting Person*
OO
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Steve Smith
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
780,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
780,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
780,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.21%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Al Schwenck
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
45,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
45,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
45,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.01%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Marta Schwenck
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
45,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
45,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
45,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.01%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Jean Stack
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
72,250
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
72,250
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
72,250
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.02%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Bill Reinhard
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
0
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
0
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.00%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Scott Webber
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
60,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
60,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
60,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.02%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Hugh G. Nolan
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
250,000
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
250,000
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
250,000
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.07%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Marc Kelley
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
34,150
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
34,150
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
34,150
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.01%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Courtlandt G. Miller
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
7,800
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
396,370
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
396,370
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.11%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Peter R. Culpepper
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
3,474,998
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
3,474,998
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
3,474,998
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.95%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Robert Taurosa
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
0
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
0
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.00%
|
|
14
|
|
Type of Reporting Person*
IN
|
|
*
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
|
|
|
|
|
|
|
|
|
1
|
|
Name of
Reporting Persons
Calvin Wallen III
|
|
2
|
|
Check the Appropriate Box if a Member
of a Group*
(a) ☒ (b) ☐
|
|
3
|
|
SEC Use Only
|
|
4
|
|
Source of Funds*
PF
|
|
5
|
|
Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐
|
|
6
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
7
|
|
Sole Voting Power
0
|
|
|
8
|
|
Shared Voting Power
0
|
|
|
9
|
|
Sole Dispositive Power
0
|
|
|
10
|
|
Shared Dispositive Power
0
|
|
|
|
|
|
|
|
|
|
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
|
12
|
|
Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares* ☐
|
|
13
|
|
Percent of Class Represented by Amount
in Row (11)
0.00%
|
|
14
|
|
Type of Reporting Person*
IN
|
SEE INSTRUCTIONS BEFORE FILLING OUT!
|
Item 1.
|
Security and Issuer
|
This Amendment No. 1 to a Statement on Schedule 13D (this
“Statement”) relates to common stock, par value $0.001 per share (“Common Stock”), of Provectus Biopharmaceuticals, Inc. (the “Issuer”). The address of the principal executive office of the Issuer is: 7327 Oak Ridge
Highway, Suite A, Knoxville, Tennessee 37931.
|
Item 4.
|
Purpose of Transaction
|
On February 28, 2017, a person representing the Reporting Persons
(“Investors”), informed the Issuer that, if investor commitments for at least $8 million were obtained, the Investors proposed to purchase for between $8 million and $20 million units consisting of common stock and a new
Preferred Stock of the Issuer. The communication included a draft Term Sheet relating to the proposed investment. As the Issuer was told that at that time, the Investor commitments were less than the minimum amount necessary to cause agreements
regarding the commitments that had been made to be effective. Therefore, the Investors’ commitments were not at the time effective. One of the conditions to the proposed financing was that all the officers and directors of the Issuer
resign and persons designated by the Investors be elected to the Board.
On March 4, 2017, the Issuer issued a press release in which it announced that it had received a proposal from two investor groups, one of which was the
Investors. On the same day, the Issuer’s lawyers sent a lawyer for representatives of the Investors a brief comparison of the two financing proposals and said that the Issuer’s Board had deemed the Investor proposal to be far inferior to
the other proposal. On March 8, a representative of the Investors responded, through lawyers, that the Investors had no interest in investing on the terms of the other proposal, and in view of the Board’s belief that the Investor proposal
was far inferior to the other proposal, the Investors were withdrawing their proposal. However, the representative of the Investors said that if the other group is not able to provide the described financing, or for any other reason the
Issuer’s Board decides that it would like to pursue a financing by the Investors on the terms they had proposed, the principal Investors would try to revive that proposal.
Despite the fact that the Investors had withdrawn their proposal, in order to be prepared to provide funds they believe are critical to the Issuer if the
Issuer asked them to revive their proposal, by March 19, 2017, all the Investors agreed that they would commit to invest even though there were only $6 million in commitments. Therefore, their commitments became effective.
On March 20, 2017, the Issuer announced that it had entered into a Definitive Financing Commitment Term Sheet with a group of its shareholders. The press
release containing that announcement said that the Issuer had previously received two unsolicited proposals relating to potential equity financings and that its board of directors had rejected the Investors’ proposal because, among other
reasons, “the financial terms of [the proposal] were determined to be detrimental to the future of the Company as an ongoing concern.” On March 23, 2017, the Issuer filed a Report on Form
8-K
with the Securities and Exchange Commission in which it described the terms of an amended and restated Definitive Commitment Term Sheet. What it described was a financing in the form of a secured convertible loan, secured by a first priority
security interest in the Issuer’s intellectual property.
On March 24, 2017, a representative of the Investors sent a letter to the directors of
the Issuer in which he said that the transaction described in the Form
8-K
would constitute a waste of corporate assets and that unless the Investors receive assurance by March 27, 2017 that the Issuer
will not enter into the transaction described in the Form
8-K,
they are going to institute litigation in the Delaware courts to prevent the Issuer from entering into that transaction and to hold the directors
personally liable for the costs the Issuer has incurred in connection with that transaction and in connection with a recently terminated rights offering.
On March 27, a lawyer for the Issuer responded by stating that if the Investors made a proposal that did not involve Peter R. Culpepper, the
Issuer’s Board would consider it. On March 28, 2017, the representative of the Investors responded that they would accept that condition and stated that the Investors would like to begin right away working on the documents regarding the
financing transaction they have proposed.
On April 14, 2017, the agreements by which the Investors committed to purchase securities of the Issuer were
terminated, and therefore, the Investors no longer were a group and no longer constituted a person for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
This Statement constitutes an exit filing because the Investors no longer are required to file a Statement on Schedule 13D with regard to the Issuer.
POWER OF ATTORNEY
The Investor appoints Courtlandt Miller as the Investor’s true and lawful
attorney-in-fact
and agent, with full power of substitution, to sign for the Investor in the Investor’s name any or all Notifications on Schedule 13D and any and
all other documents, and all amendments to Notifications on Schedule 13D or other documents, that may be filed with the Securities and Exchange Commission relating to a proposal by the Investors to purchase Units from Provectus or the purchase of
Units by the Investors, and all exhibits to Notifications and other documents filed with the Securities and Exchange Commission.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
Dated: April 17, 2017
|
|
|
|
By:
|
|
/s/ Courtlandt G. Miller
|
|
|
|
|
|
|
|
Courtlandt G. Miller
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Charles Littlejohn*
|
|
|
|
|
|
|
|
Charles Littlejohn
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Jeffrey A. Morris*
|
|
|
|
|
|
|
|
Jeffrey A. Morris
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Marilyn Thornton*
|
|
|
|
|
|
|
|
Trustee, James F Boyle Jr Credit Shelter Trust
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
John G. Gazonas*
|
|
|
|
|
|
|
|
John G. Gazonas
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
James D. Watson*
|
|
|
|
|
|
|
|
James D. Watson
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Christopher Rossman*
|
|
|
|
|
|
|
|
Managing Member, Times 11, LLC
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Steve Smith*
|
|
|
|
|
|
|
|
Steve Smith
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Al Schwenck*
|
|
|
|
|
|
|
|
Al Schwenck
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Marta Schwenck*
|
|
|
|
|
|
|
|
Marta Schwenck
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Jean Stack*
|
|
|
|
|
|
|
|
Jean Stack
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Bill Reinhard*
|
|
|
|
|
|
|
|
Bill Reinhard
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Scott Webber*
|
|
|
|
|
|
|
|
Scott Webber
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Robert Taurosa*
|
|
|
|
|
|
|
|
Robert Taurosa
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Hugh G. Nolan*
|
|
|
|
|
|
|
|
Hugh G. Nolan
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Marc Kelley*
|
|
|
|
|
|
|
|
Marc Kelley
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Peter R. Culpepper*
|
|
|
|
|
|
|
|
Peter R. Culpepper
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
Calvin Wallen III*
|
|
|
|
|
|
|
|
Calvin Wallen III
|
|
|
|
|
|
*By:
|
|
/s/ Courtlandt Miller
|
|
|
|
Courtlandt Miller
|
|
|
|
Attorney in Fact
|
Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
